Biotech-Focused Fund Adds Million: Immunome Bet Surges
A leading biotech-focused fund just boosted its Immunome position by a material amount as the stock surged. This arti...
Index values follow a defined daily schedule so investors know when to expect updates. This brief explains the publication times and how to use the data in your investing routine.
21,512 articlesA leading biotech-focused fund just boosted its Immunome position by a material amount as the stock surged. This arti...
Prospect Capital offers a striking 20%+ yield, but its long-run performance raises questions. This article lays out a...
Palantir stock plunging today is drawing attention from traders and long-term investors alike. This article breaks do...
The chatter around a SpaceX IPO has investors buzzing, but hype can blur fundamentals. This guide breaks down what to...
If you have $1,000 to invest today, you don’t have to chase every hot trend. Two unstoppable growth stocks right—NVID...
When a seasoned media veteran weighs in on CNN, it’s more than a rumor. This article translates that talk into action...
A high-profile insider sale at a growing regional bank has investors weighing motives and market signals. This guide ...
A flurry of news sent Kymera Therapeutics stock popping this week. From trial milestones to new price targets and ins...
The quantum race isn’t just about flashy qubit players. The real upside sits in the infrastructure that makes quantum...
Momentum can flip quickly in growth stocks, but today some names look cheap for the upside potential. This guide high...
Curious if you can own SpaceX stock before its IPO through Hyperliquid? This guide explains why that pre-IPO thrill o...
Sandisk stock sinking today grabbed headlines as intraday gains faded amid broader market jitters. This article break...